Aperio Group’s Phibro Animal Health PAHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-20,072
Closed -$349K 2445
2020
Q3
$349K Buy
20,072
+3,694
+23% +$78.8K ﹤0.01% 2001
2020
Q2
$430K Sell
16,378
-4,095
-20% -$102K ﹤0.01% 1835
2020
Q1
$495K Sell
20,473
-7,455
-27% -$182K ﹤0.01% 1653
2019
Q4
$694K Buy
27,928
+9,506
+52% +$221K ﹤0.01% 1633
2019
Q3
$393K Buy
18,422
+3,837
+26% +$105K ﹤0.01% 1886
2019
Q2
$463K Buy
14,585
+500
+4% +$15.7K ﹤0.01% 1821
2019
Q1
$465K Sell
14,085
-561
-4% -$17.5K ﹤0.01% 1789
2018
Q4
$471K Buy
14,646
+3,734
+34% +$141K ﹤0.01% 1719
2018
Q3
$468K Buy
10,912
+54
+0.5% +$2.55K ﹤0.01% 1801
2018
Q2
$500K Buy
10,858
+576
+6% +$25.5K ﹤0.01% 1742
2018
Q1
$408K Buy
10,282
+329
+3% +$12.2K ﹤0.01% 1791
2017
Q4
$334K Buy
9,953
+65
+0.7% +$2.31K ﹤0.01% 1894
2017
Q3
$367K Sell
9,888
-210
-2% -$7.89K ﹤0.01% 1824
2017
Q2
$374K Buy
10,098
+551
+6% +$18K ﹤0.01% 1785
2017
Q1
$269K Buy
9,547
+1,743
+22% +$49.2K ﹤0.01% 1877
2016
Q4
$229K Buy
+7,804
New +$213K ﹤0.01% 1930

Other funds holding PAHC

Aperio Group's PAHC Position: Q4 2020 in Review

Aperio Group sold out of Phibro Animal Health (PAHC) in Q4 2020, closing a stake of 20,072 shares — an estimated $349K sold.

Aperio Group first reported a position in PAHC in Q4 2016 and held it in 16 quarters. The position peaked at $694K in Q4 2019. 136 funds tracked by Wall St. Rank hold PAHC as of Q4 2020.

  • Aperio Group reported no remaining Phibro Animal Health position as of Q4 2020 after selling out during the quarter.
  • Aperio Group sold 20,072 Phibro Animal Health shares in Q4 2020, an estimated $349K.
  • Aperio Group first reported a position in Phibro Animal Health in Q4 2016 and held it in 16 quarters.
  • Aperio Group's Phibro Animal Health position peaked at $694K in Q4 2019.
  • 136 funds tracked by Wall St. Rank held Phibro Animal Health as of Q4 2020.

Based on Aperio Group's 13F filing for Q4 2020, filed 5 Feb 2021.